Received May 12, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
| MNQ | MENINGOCOCCAL CONJUGATE (MENACTRA) | SANOFI PASTEUR | UNK | — | — |
| TDAP | TDAP (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
aches; fever; headaches; This spontaneous report was received from a/an Administrator / Supervisor (Field based employee) and refers to a(n) female patient (friend's daughter) of unknown age. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 04-May-2026 (reported as 2 days ago), the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), administered for prophylaxis (dose, strength, route, anatomical site, lot # and expiration date were not reported). On the same day, the patient was also vaccinated with Diphtheria vaccine toxoid;Pertussis vaccine acellular;Tetanus vaccine toxoid (Tdap) and Meningococcal vaccine A/C/Y/W conj (dip tox) (Menactra) (dose, strength, route, anatomical site, indication, lot # and expiration date were not reported). The patient developed aches, headaches, and fever. No additional AE/No PQC reported. At the reporting time, the outcome of all events was unknown. The action taken with suspect vaccines was not applicable. The causal relationship between all events and suspect vaccines was unknown/not reported/not provided. Lot# is being requested and will be submitted if received.